Cargando…

Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease

Clostridioides difficile infection (CDI) and inflammatory bowel disease (IBD) are two pathologies that share a bidirectional causal nexus, as CDI is known to have an aggravating effect on IBD and IBD is a known risk factor for CDI. The colonic involvement in IBD not only renders the host more prone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Vecchio, Livio Enrico, Fiorani, Marcello, Tohumcu, Ege, Bibbò, Stefano, Porcari, Serena, Mele, Maria Cristina, Pizzoferrato, Marco, Gasbarrini, Antonio, Cammarota, Giovanni, Ianiro, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319314/ https://www.ncbi.nlm.nih.gov/pubmed/35889034 http://dx.doi.org/10.3390/microorganisms10071315

Ejemplares similares

The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota
por: Fiorani, Marcello, et al.
Publicado: (2023)

Gut microbiota and immunotherapy of renal cell carcinoma
por: Bibbò, Stefano, et al.
Publicado: (2023)

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022)

COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms
por: Settanni, Carlo Romano, et al.
Publicado: (2021)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Role of gut microbiome on immunotherapy efficacy in melanoma
por: Bibbò, Stefano, et al.
Publicado: (2021)

Prior Misdiagnosis of Celiac Disease Is Common Among Patients Referred to a Tertiary Care Center: A Prospective Cohort Study
por: Ianiro, Gianluca, et al.
Publicado: (2016)

T.03.10 HENOCH-SCHONLEIN PURPURA FOLLOWING EXPOSURE TO SARS-COV2 MRNA VACCINE: A CASE REPORT
por: Di Vincenzo, F., et al.
Publicado: (2022)

How the gut parasitome affects human health
por: Ianiro, Gianluca, et al.
Publicado: (2022)

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease
por: van Lingen, Emilie (E.), et al.
Publicado: (2023)

Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis
por: Song, Yi Nong, et al.
Publicado: (2021)

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
por: Airola, Carlo, et al.
Publicado: (2023)

Gastric non-secreting neuroendocrine tumor and hypochlorhydria-related hypergastrinemia: a case report
por: Biolato, Marco, et al.
Publicado: (2013)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota
por: Fusco, William, et al.
Publicado: (2023)

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
por: Bibbò, Stefano, et al.
Publicado: (2018)

The interplay of Clostridioides difficile infection and inflammatory bowel disease
por: Sehgal, Kanika, et al.
Publicado: (2021)

Digestive Enzyme Supplementation in Gastrointestinal Diseases
por: Ianiro, Gianluca, et al.
Publicado: (2016)

Management of Clostridioides difficile infection in patients with inflammatory bowel disease
por: Khanna, Sahil
Publicado: (2021)

Wheat desensitization treatment in patients with gluten sensitivity
por: Nucera, Eleonora, et al.
Publicado: (2018)

The Current Knowledge on Clostridioides difficile Infection in Patients with Inflammatory Bowel Diseases
por: Boeriu, Alina, et al.
Publicado: (2022)

Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
por: Ianiro, Gianluca, et al.
Publicado: (2022)

Endoscopic evaluation of celiac disease
por: Cammarota, Giovanni, et al.
Publicado: (2016)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure
por: Pizzoferrato, Marco, et al.
Publicado: (2022)

Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study
por: Papa, Alfredo, et al.
Publicado: (2022)

A preliminary study of bowel rest strategy in the management of Clostridioides difficile infection
por: Sugimoto, Hiroshi, et al.
Publicado: (2020)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

A Durum Wheat Variety-Based Product Is Effective in Reducing Symptoms in Patients with Non-Celiac Gluten Sensitivity: A Double-Blind Randomized Cross-Over Trial
por: Ianiro, Gianluca, et al.
Publicado: (2019)

Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
por: Lam, Angela Y., et al.
Publicado: (2020)

Novel risk factors and outcomes in inflammatory bowel disease patients with Clostridioides difficile infection
por: Voth, Elida, et al.
Publicado: (2021)

Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4p9jgmtkivval1l7kiolemokpd